Drug class
Vaginal Estrogens
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings. Read more about Vaginal Estrogens
47 drugs in this class 24 manufacturers
Drugs in Vaginal Estrogens
FEMRING (estradiol acetate)
ELURYNG (etonogestrel/ethinyl estradiol)
INTRAROSA (prasterone (DHEA))
NUVARING (etonogestrel/ethinyl estradiol)
HALOETTE (etonogestrel/ethinyl estradiol)
ENILLORING (etonogestrel/ethinyl estradiol)
IMVEXXY STARTER PACK (estradiol)
IMVEXXY MAINTENANCE PACK (estradiol)
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings.
They function by activating nuclear estrogen receptors in the urogenital epithelium, which restores mucosal thickness, enhances vaginal elasticity, and normalizes physiological pH with minimal systemic absorption.
This drug class is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), specifically relieving moderate-to-severe vulvar and vaginal atrophy, dyspareunia, and associated lower urinary tract symptoms or recurrent urinary tract infections.
-
medlineplus.gov
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings
-
nih.gov
Vaginal estrogens are a therapeutic class of locally administered hormonal medications formulated as creams, tablets, inserts, or rings They function by activating nuclear estrogen receptors in the urogenital epithelium, which restores mucosal thickness, enhances vaginal elasticity, and normalizes physiological pH with minimal systemic absorption This drug class is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), specifically relieving moderate-to-severe vulvar...
-
fda.gov
They function by activating nuclear estrogen receptors in the urogenital epithelium, which restores mucosal thickness, enhances vaginal elasticity, and normalizes physiological pH with minimal systemic absorption
-
fda.gov
This drug class is primarily indicated for the treatment of genitourinary syndrome of menopause (GSM), specifically relieving moderate-to-severe vulvar and vaginal atrophy, dyspareunia, and associated lower urinary tract symptoms or recurrent urinary tract infections
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.